ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 194 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,611,000 | -77.2% | 30,550 | -69.0% | 0.19% | -77.2% |
| Q2 2018 | $11,431,000 | +128.3% | 98,631 | +59.3% | 0.83% | +119.1% |
| Q1 2018 | $5,008,000 | +182.0% | 61,901 | +63.0% | 0.38% | +211.6% |
| Q3 2017 | $1,776,000 | +361.3% | 37,967 | +203.5% | 0.12% | +348.1% |
| Q1 2017 | $385,000 | +4.6% | 12,510 | -9.6% | 0.03% | 0.0% |
| Q3 2016 | $368,000 | -70.2% | 13,832 | -74.3% | 0.03% | -78.4% |
| Q3 2013 | $1,234,000 | – | 53,863 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |